|
|||||
|
|
Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent,platinum‐sensitive ovarian,fallopian tube,or primary peritoneal cancer |
|
| Authors: | Marcela G. del Carmen MD MPH Jeff G. Supko PhD Nora K. Horick MS J. Alejandro Rauh‐Hain MD Rachel M. Clark MD Susana M. Campos MD MPH Carolyn N. Krasner MD Tina Atkinson RN Michael J. Birrer MD PhD |
| Affiliation: | 1. Division of Gynecologic Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts;2. Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts;3. Department of Biostatistics, Massachusetts General Hospital, Boston, Massachusetts;4. Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts |
| Abstract: | |
| Keywords: | carboplatin‐pralatrexate chemotherapy pharmacokinetics recurrent ovarian cancer |